Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hepion Pharmaceuticals, Inc. - Common Stock (NQ: HEPA )

0.1350 -0.1868 (-58.05%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Hepion Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales
Via Benzinga
Exposures Fossil Fuels
Nasdaq Surges 1.5%; Procter & Gamble Posts Upbeat Earnings
Via Benzinga
US Stocks Higher; Netflix Profit Beats Estimates
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Deckers Outdoor Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
HEPA Stock Earnings: Hepion Pharmaceuticals Reported Results for Q2 2024
Hepion Pharmaceuticals just reported results for the second quarter of 2024. 
Via InvestorPlace
Fatty-Liver Focused Hepion Pharmaceuticals Agrees To Merge With Israel-Based Parkinson's Disease Drug Developer
Hepion Pharmaceuticals announces merger with Pharma Two B Ltd., creating a combined company focused on Parkinson's disease treatment. The merger values Hepion at $58.5 million, and Pharma Two B plans... 
Via Benzinga
HEPA Stock Earnings: Hepion Pharmaceuticals Reported Results for Q1 2024
Hepion Pharmaceuticals just reported results for the first quarter of 2024. 
Via InvestorPlace
S&P 500 Rises Over 1%; Zions Bancorp Shares Gain After Q1 Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday?
Updates on Hepion Pharmaceuticals' ASCEND-NASH Trial, now in wind-down phase. Explore insights into Phase 2b study progression and strategic alternatives. 
Via Benzinga
Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Gold Falls Sharply; Matterport Shares Spike Higher
Via Benzinga
Nike Layoffs 2024: What to Know About the Latest Nike Job Cuts
Nike layoffs are on the way as the athletic wear company is preparing to cut 740 jobs in two rounds at its global headquarters. 
Via InvestorPlace
Topics Workforce
Exposures Layoff
Dow Jumps Over 100 Points; Chicago Fed National Activity Rises In March
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Is Hepion Pharmaceuticals (HEPA) Stock Down 41% Today?
Hepion Pharmaceuticals stock is falling on Monday as investors in HEPA learn of the company winding down a Phase 2b clinical trial. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start ofd the trading week with a look at the biggest pre-market stock movers traders need to watch on Monday morning! 
Via InvestorPlace
HEPA Stock Earnings: Hepion Pharmaceuticals Beats EPS for Q4 2023
HEPA stock results show that Hepion Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Over $18M Bet On Asana? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed lower on Wednesday following Fed’s rate decision, there were a few notable insider trades. 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.